Learn bits
Health & Medicine
Mahesh

07/09/22 13:51 PM IST

India's first intranasal Covid vaccine by Bharat Biotech gets DCGI approval

In News 
  • India's first intranasal Covid vaccine by Bharat Biotech received DCGI approval for primary immunization against the infection for people above the age of 18.
About Intranasal Vaccine 
  • The intranasal vaccine for COVID-19 by Bharat Biotech is first of its kind needle-free vaccine.
  • Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.
iNCOVACC
  • The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
  • This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results.
  • This vaccine has been specifically formulated to allow intranasal delivery through nasal drops.
  • The nasal delivery system has been designed and developed to be cost-effective in low and middle-income countries.
  • The intranasal vaccine is a heterologous booster dose.
Source- Live Mint 

More Related Current Affairs View All

05 Mar

First-ever comprehensive survey of India’s river dolphins

'Prime Minister Narendra Modi released the results of the first-ever comprehensive population estimation of riverine dolphins – Gangetic and Indus dolphins – done in In

Read More

05 Mar

Arresting women at night

'The Madurai Bench of the Madras High Court in Deepa versus S. Vijayalakshmi and Others ruled that the legal provision in the Bharatiya Nagarik Suraksha Sanhita (BNSS), 2023, which

Read More

05 Mar

Digital Personal Data Protection Act, 2023

'The Ministry of Electronics and Information Technology (MeitY) looking to wrap up public consultations on the draft Rules for the Digital Personal Data Protection Act, 2023 by Mar

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps